About
Nosis Bio develops receptor-targeted RNA medicines using AI-guided design and delivery technologies to achieve gene silencing across various cell types for treating chronic diseases.
Explore Nosis Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.